Abstract
This study was performed to provide evidence, albeit indirectly, as to which matrix metalloproteinases (MMPs), among the gelatinases MMP-2 and MMP-9 and the collagenases MMP-1 and MMP-13, play a more proactive role in the angiogenic process in arthritic joint. Joint fluid was collected from 33 patients with rhuematoid arthritis (RA) and osteoarthritis (OA), and protein (MMPs and vascular endothelial growth factor (VEGF)) levels were measured by ELISA, and the association of MMPs with VEGF was evaluated in joint fluid of patients with RA or OA. The levels of collagenases (total MMP-1 and total MMP-13) and gelatinases (total MMP-2 and total MMP-9) in RA joint fluid were significantly higher than those in OA fluid. Total MMP-9 levels were significantly associated with VEGF levels in RA fluids, but not in OA fluid, while total MMP-13 levels were strongly associated with VEGF levels in both RA and OA fluid. However, total MMP-2 and total MMP-1 levels were not associated with VEGF levels in either RA or OA joint fluid. Our results indirectly suggest that in RA and OA, MMP-9 and MMP-13 may play a more important role in angiogenesis than MMP-2 and MMP-1.
References
Murphy G, Knauper V, Atkinson S, Butler G, English W, Hutton M et al (2002) Matrix metalloproteinases in arthritic disease. Arthritis Res 4(Suppl 3):S39–S49
Burrage PS, Mix KS, Brinckerhoff CE (2006) Matrix metalloproteinases: role in arthritis. Front Biosci 11:529–543
Weber AJ, De Bandt M (2000) Angiogenesis: general mechanisms and implications for rheumatoid arthritis. Joint Bone Spine 67(5):366–383
Burbridge MF, Coge F, Galizzi JP, Boutin JA, West DC, Tucker GC (2002) The role of the matrix metalloproteinases during in vitro vessel formation. Angiogenesis 5(3):215–226
Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D et al (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93(3):411–422
Yu Q, Stamenkovic I (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14(2):163–176
Zijlstra A, Aimes RT, Zhu D, Regazzoni K, Kupriyanova T, Seandel M et al (2004) Collagenolysis-dependent angiogenesis mediated by matrix metalloproteinase-13 (collagenase-3). J Biol Chem 279(26):27633–27645
Netzel-Arnett S, Mitola DJ, Yamada SS, Chrysovergis K, Holmbeck K, Birkedal-Hansen H et al (2002) Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity. J Biol Chem 277(47):45154–45161
Kim KS, Park EK, Ju SM, Jung HS, Bang JS, Kim C et al (2007) Taurine chloramine differentially inhibits matrix metalloproteinase 1 and 13 synthesis in interleukin-1beta stimulated fibroblast-like synoviocytes. Arthritis Res Ther 9(4):R80
Bouis D, Kusumanto Y, Meijer C, Mulder NH, Hospers GA (2006) A review on pro- and anti-angiogenic factors as targets of clinical intervention. Pharmacol Res 53(2):89–103
Wang H, Keiser JA (1998) Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Circ Res 83(8):832–840
Fraser A, Fearon U, Reece R, Emery P, Veale DJ (2001) Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis. Arthritis Rheum 44(9):2024–2028
Goldbach-Mansky R, Lee JM, Hoxworth JM, Smith D II, Duray P, Schumacher RH Jr et al (2000) Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis. Arthritis Res 2(2):145–153
Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K et al (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2(10):737–744
Heilpern AJ, Wertheim W, He J, Perides G, Bronson RT, Hu LT (2009) Matrix metalloproteinase 9 plays a key role in lyme arthritis but not in dissemination of Borrelia burgdorferi. Infect Immun 77(7):2643–2649
Itoh T, Matsuda H, Tanioka M, Kuwabara K, Itohara S, Suzuki R (2002) The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J Immunol 169(5):2643–2647
Sang QX (1998) Complex role of matrix metalloproteinases in angiogenesis. Cell Res 8(3):171–177
Tchetverikov I, Ronday HK, Van El B, Kiers GH, Verzijl N, TeKoppele JM et al (2004) MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis. Ann Rheum Dis 63(7):881–883
Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K et al (2000) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 59(6):455–461
Acknowledgments
This work was supported by a research grant from the Kyung Hee University in 2009 (KHU-20100134).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, K.S., Choi, H.M., Lee, YA. et al. Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis. Rheumatol Int 31, 543–547 (2011). https://doi.org/10.1007/s00296-010-1592-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-010-1592-1